Article No
CY-8107
CircuLex Human Calprotectin ELISA Kit
CircuLex Human Calprotectin ELISA Kit
Assay & Detection
Specifications
| Application | ELISA |
| Article No | CY-8107 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
| Components | Microplate, 10X Wash Buffer, Dilution Buffer, Hhuman Calprotectin Standard, 100x HRP conjugated Detection Antibody, Substrate Reagent, Stop Solution |
| Description | CircuLex Human Calprotectin ELISA Kit |
| Supplier | MBL |
| Additional Information | This kit is used for the quantitative measurement of human calprotectin in serum, plasma and other biological media.<br /><br /> Samples:Serum, Plasma, Other biological media <br />Measurement range:1-64 ng/mL <br />Sensitivity:0.145 ng/mL- |
| Notes | In human, S100A9 is usually co-expressed with S100A8, and they form heterodimeric complexes, which was named as calprotectin. Fecal calprotectin is a marker for inflammatory gastrointestinal as well as neoplastic diseases. It is often difficult to distinguish between IBD and irritable bowel syndrome (IBS). This leads in many cases to extensive and unnecessary colonoscopic examinations. Fecal calprotectin may be a useful marker for discriminating between patients with IBD and IBS. In addition, fecal calprotectin levels correlate significantly with histologic and endoscopic assessment of disease activity in Crohn's disease and ulcerative colitis. |
| Product Type | Assay & Detection |
| Research area | Immunology |
| Shipping Information | 4°C |
| Size | 96 Assays |
| Species Reactivity | human |
| Storage | 4°C |
| Technical Specifications | In human, S100A9 is usually co-expressed with S100A8, and they form heterodimeric complexes, which was named as calprotectin. Fecal calprotectin is a marker for inflammatory gastrointestinal as well as neoplastic diseases. It is often difficult to distinguish between IBD and irritable bowel syndrome (IBS). This leads in many cases to extensive and unnecessary colonoscopic examinations. Fecal calprotectin may be a useful marker for discriminating between patients with IBD and IBS. In addition, fecal calprotectin levels correlate significantly with histologic and endoscopic assessment of disease activity in Crohn's disease and ulcerative colitis. |
| Product Page Updated | 2023-12-29T16:20:16.638Z |
